Basel

SAS wins three Risk.net Risk Technology Awards

Retrieved on: 
Tuesday, August 9, 2022
Risk, Senior, PnL Explained, AI, Basel, Environment, Compliance, Capital requirement, SAS, IFRS, Automation, ORRF Risk Research Forum, Weather, Science and technology in Asia, Solution, Muscle, Organization, Risk management, Online shopping

CARY, N.C., Aug. 9, 2022 /PRNewswire/ -- SAS has again scored a collection of wins from the 2022 Risk Technology Awards, Risk.net's prestigious annual awards series recognizing the best in enterprise, operational, and credit risk technology. According to a panel of judges comprised of Risk.net editors and risk technology users, the artificial intelligence and analytics leader reigns supreme in three categories:

Key Points: 
  • This integrated and highly collaborative risk platform provides a virtual headquarters for model development, data integration and workflow planning and execution across risk and finance.
  • Without state-of-the-art credit risk modeling, banks and fintechs cannot deliver the consistent customer experience today's consumers demand.
  • In SAS' integrated ecosystem, automated credit decisions, detailed metrics, and turnkey, compliant risk models are a click away.
  • With SAS' new Basel IV configuration, clients can prepare for changes in regulation and simulate credit risk approaches to weather the storm.

CBOA Financial, Inc. Reports Consolidated Earnings of $747,000 in 2Q 2022

Retrieved on: 
Friday, July 29, 2022
Efficiency ratio, Bank, Federal Reserve, CEO, Solution, Small Business Administration, Commerce, Federal Reserve responses to the subprime crisis, Commerce Bank, Policy, CBOF, Company, Net interest margin, SBA, Basel

Total assets increased by 2.4% to $363.5 million during the quarter ended June 30, 2022, and increased 8.0% compared to $336.5 million a year ago.

Key Points: 
  • Total assets increased by 2.4% to $363.5 million during the quarter ended June 30, 2022, and increased 8.0% compared to $336.5 million a year ago.
  • Gross loans increased $19.4 million since first quarter 2022, ending the second quarter 2022 at $257 million.
  • The Allowance for Loan Losses totaled $3.7 million at June 2022, or 1.44% of loans, unchanged from the previous quarter.
  • At June 30, 2022, tangible book value was $2.79 per share compared to $2.89 per share at March 31, 2022 and $3.16 per share a year ago.

Security Federal Corporation Announces Second Quarter Earnings

Retrieved on: 
Friday, July 29, 2022
Investment, Financial Accounting Standards Board, Insurance, Trust, U.S. Securities and Exchange Commission, Private Securities Litigation Reform Act, Bank, COVID-19, Public health, Finance, Company, Method, Consumer Protection Act, Security (finance), PPP, Annual report, Dodd–Frank Wall Street Reform and Consumer Protection Act, Secure Federal File Sharing Act, Basel

Security Federal has 18 full service branches located in Aiken, Ballentine, Clearwater, Columbia, Graniteville, Langley, Lexington, North Augusta, Ridge Spring, Wagener and West Columbia, South Carolina and Augusta and Evans, Georgia.

Key Points: 
  • Security Federal has 18 full service branches located in Aiken, Ballentine, Clearwater, Columbia, Graniteville, Langley, Lexington, North Augusta, Ridge Spring, Wagener and West Columbia, South Carolina and Augusta and Evans, Georgia.
  • A full range of financial services, including trust and investments, are provided by the Bank and insurance services are provided by the Banks wholly owned subsidiary, Security Federal Insurance, Inc.
  • The Banks newest branch, located in Augusta, Georgia, is under construction but scheduled to open later this year.
  • Accordingly, these factors should be considered in evaluating forward-looking statements, and undue reliance should not be placed on such statements.

ACNB Corporation Reports 2022 Second Quarter and Year-To-Date Financial Results

Retrieved on: 
Friday, July 29, 2022
Income, Sale, Coronavirus, Intention, Attack, Report, Director, Security (finance), Basel, System integration, Acquisition, Investment, Federal Reserve, Environment, Federal, Trust, U.S. Securities and Exchange Commission, Paycheck Protection Program, Hockley, Ownership, Bank, Compte rendu, Total, Technology, Risk management, Life, Growth, GLOBE, Insurance, Industry, SAFE, SEC, Government, Information technology, Health, Failure, Board, COVID-19, Finance, ACNB, Federation, Tax, Risk, Corporation, Financial Accounting Standards Board, Forward-looking statement, Terrorism, NASDAQ, PPP, Terminology, Life insurance, Real estate, Holding company, Car rental, Management, Financial services, Lithium, LLC, MD

GETTYSBURG, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced financial results for the three months ended June 30, 2022, with net income of $8,630,000. Compared to net income of $8,508,000 for the three months ended June 30, 2021, this was an increase of $122,000 or 1.43% from comparable period results. The increase in net income for the three months ended June 30, 2022, was driven by increases in net interest income of $1,235,000 and commissions from insurance sales of $955,000. The increase in net interest income was a result of the rise in net interest margin of 8 basis points and in average earning assets of $96,303,000 period over period. The increase in commissions from insurance sales was primarily attributable to the acquisition of the business and assets of Hockley & O’Donnell Insurance Agency in the first quarter of 2022. The acquisition added $719,000 of revenue during the second quarter of 2022. For the three months ended June 30, 2022 and 2021, basic earnings per share was $0.99 and $0.98, respectively, which is an increase of $0.01 per share or 1.02%.

Key Points: 
  • ACNB Corporation repurchased 88,225 shares of ACNB Corporation common stock during the second quarter of 2022 at a cost of $2,905,000.
  • Effective June 1, 2022, Jason H. Weber became Executive Vice President/Treasurer & Chief Financial Officer of ACNB Corporation and ACNB Bank.
  • GETTYSBURG, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced financial results for the three months ended June 30, 2022, with net income of $8,630,000.
  • Further, ACNB Corporation repurchased 88,225 shares of ACNB Corporation common stock during the second quarter of 2022 at a cost of $2,905,000.

Euroclear delivers a strong performance for H1 2022

Retrieved on: 
Monday, July 25, 2022
Investment, Rural sociology, Sustainability Accounting Standards Board, EUR, Climate, UMR, Intention, Risk, Board, Safety, Belgium, Technology, Sweden, Efficiency, International, ESG, Automation, Basel, Security (finance), Construction, Euroclear

Euroclear continues to see very strong demand for collateral management and lending services from a broad range of market participants.

Key Points: 
  • Euroclear continues to see very strong demand for collateral management and lending services from a broad range of market participants.
  • In the second quarter, Euroclear launched a new ESG reporting solution for asset managers, through the combination of MFEX by Euroclear and Greenomy, two recent investments.
  • Guided by its purpose, Euroclear innovates to bring safety, efficiency and connections to financial markets for sustainable economic growth.
  • The Euroclear group comprises Euroclear Bank, the International CSD, as well as Euroclear Belgium, Euroclear Finland, Euroclear France, Euroclear Nederland, Euroclear Sweden, Euroclear UK & International and MFEX by Euroclear.

Euroclear delivers a strong performance for H1 2022

Retrieved on: 
Monday, July 25, 2022
Investment, Rural sociology, Sustainability Accounting Standards Board, EUR, Climate, UMR, Intention, Risk, Board, Safety, Belgium, Technology, Sweden, Efficiency, International, ESG, Automation, Basel, Security (finance), Construction, Euroclear

Euroclear continues to see very strong demand for collateral management and lending services from a broad range of market participants.

Key Points: 
  • Euroclear continues to see very strong demand for collateral management and lending services from a broad range of market participants.
  • In the second quarter, Euroclear launched a new ESG reporting solution for asset managers, through the combination of MFEX by Euroclear and Greenomy, two recent investments.
  • Guided by its purpose, Euroclear innovates to bring safety, efficiency and connections to financial markets for sustainable economic growth.
  • The Euroclear group comprises Euroclear Bank, the International CSD, as well as Euroclear Belgium, Euroclear Finland, Euroclear France, Euroclear Nederland, Euroclear Sweden, Euroclear UK & International and MFEX by Euroclear.

ACNB Corporation Announces Third Quarter Cash Dividend

Retrieved on: 
Thursday, July 21, 2022
Coronavirus, Board of directors, GLOBE, Corporation, Financial Accounting Standards Board, Insurance, Trust, Industry, Forward-looking statement, SEC, Basel, Terrorism, Information technology, COVID-19, Health, Attack, Failure, Income, Board, NASDAQ, Finance, Report, Director, Technology, Risk management, ACNB, Life, Federation, Terminology, Tax, Risk, Holding company, Bank, MD

GETTYSBURG, Pa., July 21, 2022 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced today that the Board of Directors approved and declared a regular quarterly cash dividend of $0.26 per share of ACNB Corporation common stock payable on September 15, 2022, to shareholders of record as of September 1, 2022.

Key Points: 
  • GETTYSBURG, Pa., July 21, 2022 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced today that the Board of Directors approved and declared a regular quarterly cash dividend of $0.26 per share of ACNB Corporation common stock payable on September 15, 2022, to shareholders of record as of September 1, 2022.
  • This per share amount reflects a 4.0% increase over the same quarter of 2021 and will result in aggregate dividend payments of approximately $2.2 million to ACNB Corporation shareholders in the third quarter of 2022.
  • Compared to a year ago, ACNB Corporation paid a $0.25 dividend per common share in the third quarter of 2021.
  • ACNB Corporation is pleased to continue its long history of shareholder commitment with payment, once again, of a solid quarterly cash dividend in the third quarter of 2022.

U.S. Bancorp Releases 2022 Dodd-Frank Act Stress Test Results; Receives Preliminary Stress Capital Buffer of 2.5 percent

Retrieved on: 
Monday, June 27, 2022
Banking, Professional Services, Finance, USB, Bank holding company, Acquisition, Annual report, Dodd–Frank Wall Street Reform and Consumer Protection Act, Director, CEO, Securities Exchange Act of 1934, Commercial bank, Climate change, Federal Reserve Board of Governors, Consumer Protection Act, COVID-19, Corporation, Federal Reserve, U.S. Securities and Exchange Commission, Risk, Forward-looking statement, Corporate Commercial Bank, Compliance, SCB, Private Securities Litigation Reform Act, NYSE, MUFG Union Bank, Public sector banks in India, Social responsibility, Unemployment, Federal, Payment Services Directive, Share repurchase, CECL, Basel, Security (finance), Financial adviser, Renewable energy, Risk management, Bank, Public relations, U.S. Bancorp

Based on its strong 2022 stress test results, the company expects to be subject to a preliminary stress capital buffer (SCB) of 2.5 percent, unchanged from the current level, for the period beginning October 1, 2022, and ending on September 30, 2023.

Key Points: 
  • Based on its strong 2022 stress test results, the company expects to be subject to a preliminary stress capital buffer (SCB) of 2.5 percent, unchanged from the current level, for the period beginning October 1, 2022, and ending on September 30, 2023.
  • The Federal Reserve has stated that it expects to finalize the SCB for all firms by August 31, 2022.
  • The companys CET1 ratio was 9.8 percent as of March 31, 2022, under transitional regulatory capital requirements related to the current expected credit losses (CECL) methodology.
  • Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
    This press release contains forward-looking statements about U.S. Bancorp.

Basilea reports progress on the implementation of its strategy to focus on anti-infectives

Retrieved on: 
Monday, June 27, 2022
LR, Patient, Ceftobiprole, Heart, Isavuconazonium, Staphylococcus aureus, Infection, Research, Mycosis, MSSA, MRSA, SAB, Mortality, Osteomyelitis, SIX Swiss Exchange, Merck, Gram-negative bacteria, Communication, Subclinical infection, MENA, FGFR, Human, Merck & Co., Safety, Disease, Basel, Bloodstream infections, Pharmaceutical industry

53 LR

Key Points: 
  • 53 LR
    Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today an update on the progress made in the implementation of its strategic focus on anti-infectives.
  • David Veitch, Chief Executive Officer, stated: We have made significant progress in the implementation of our new strategy.
  • This allows us now to make informed decisions on each asset in order to ensure that we can focus our resources on our anti-infectives business as of 2023.
  • Partnering discussions for the TTK/PLK1-inhibitor (BAL0891) and preclinical oncology assets are well advanced and expected to be concluded in H2 2022.

Cresemba® sales in Asia Pacific region trigger sales milestone payment to Basilea from Pfizer

Retrieved on: 
Friday, June 17, 2022
Cancer, I.V. (X Japan song), Mortality, Infection, Mucormycosis, Lymphatic system, Azole, Immunodeficiency, Research, SIX Swiss Exchange, Growth, Disease, USD, PFE, Adult, Patient, Communication, NYSE, CHF, Mycosis, Pharmaceutical industry, Isavuconazonium, Pfizer, Basel, EU

Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today that the sales of the antifungal Cresemba (isavuconazole) by its license partner Pfizer Inc. (NYSE: PFE, Pfizer) in the Asia Pacific region, exceeded the threshold triggering the first sales milestone payment for this region of USD 1.25 million.

Key Points: 
  • Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today that the sales of the antifungal Cresemba (isavuconazole) by its license partner Pfizer Inc. (NYSE: PFE, Pfizer) in the Asia Pacific region, exceeded the threshold triggering the first sales milestone payment for this region of USD 1.25 million.
  • David Veitch, Basileas Chief Executive Officer, stated: We are very pleased with the commercial progress of Cresemba, which has now triggered the first sales milestone payment from Pfizer for the Asia Pacific region.
  • The license agreement between Basilea and Pfizer for Cresemba covers Europe (excluding the Nordic countries) as well as countries in the Asia Pacific region and China.
  • Under the agreement with Pfizer, Basilea is eligible for additional regulatory and sales milestone payments of up to around CHF 550 million, in addition to receiving mid-teen royalties on sales.